RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sandeep Banga

Interventional Cardiology · Carbondale, ILNPI 1003266149

Payments from drug & device makers

$37,199in general payments, 2019–2025

Across 457 payments — averaging $81.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$12K
  • Medtronic$8K
  • Boston Scientific$5K
  • Bard Peripheral Vascular, Inc.$3K
  • Edwards Lifesciences$2K
  • Abiomed$1K
  • plus $7K from 34 others

What the payments were for

  • Grants$8,83324%
  • Travel & lodging$13,76537%
  • Food & beverage$14,32539%
  • Education$2761%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott38$11,537
Medtronic78$7,673
Boston Scientific61$5,245
Bard Peripheral Vascular, Inc.18$2,713
Edwards Lifesciences20$1,968
Abiomed15$1,056
E.r. Squibb & Sons, L.L.C.29$840
AstraZeneca22$822
Shockwave Medical, Inc8$787
Amgen21$550
Penumbra, Inc.5$431
Novartis25$428
Johnson & Johnson18$347
Actelion Pharmaceuticals US, Inc.8$337
Stryker5$308
Medical Device Business Services, Inc.30$304
Teleflex LLC3$257
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)7$187
Boehringer Ingelheim8$174
Cardiva Medical, Inc.3$168
Novo Nordisk2$126
Pfizer7$111
Chiesi USA, Inc.4$109
Philips North America LLC1$108
Cordis US CORP.2$95
Inari Medical, Inc.2$59
Inspire Medical Systems, Inc.1$59
Biotronik Inc.1$57
Biosense Webster, Inc.2$49
W. L. Gore & Associates, Inc.2$43
ZOLL Circulation Inc2$37
Angiodynamics, Inc.1$35
Imperative Care, Inc1$31
Heartflow, Inc.1$29
Lexicon Pharmaceuticals, Inc.1$25
Alnylam Pharmaceuticals Inc.1$24
Kestra Medical Technology Services, Inc.1$24
Kiniksa Pharmaceuticals, Ltd.1$17
Cardiovascular Systems Inc.1$16
Sanofi-aventis U.S. LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,199 in reported general payments places this provider in the 75th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$7,494
Metoprolol Succinate41$452
Carvedilol19$227
Rosuvastatin Calcium12$194
Nitroglycerin12$146
Losartan Potassium14$146
Atorvastatin Calcium12$132
Amlodipine Besylate16$37

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$111$7,49411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 303 interventional cardiology providers in Illinois.

Other interventional cardiology in Carbondale

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →